Program – Perfusion Downunder Winter Meeting 2016

Thursday 18th August 2016
Opening Remarks
Session 1:

Fine Tuning the Metabolism of the Cardiac Surgical Patient (1)

Magnesium therapy in cardiac surgery and ICU
Rinaldo Bellomo

Iron and the Cardiac Surgical patient: a changing paradigm
Sara Allan

Panel Discussion 30 minutes

1730-1830 Session 2 Keynote::
“Herding Cats and Birthing Elephants – Why is patient safety so hard?”
Joyce Wahr  

Discussion 15 minutes

Friday 19th August 2016
Session 3:

Fine Tuning the Metabolism of the Cardiac Surgical Patient (2)

pH vs alpha stat, what to do in adult aortic patients (30 min)
Tim Jones

Lactate measurements in cardiac surgical patients: value or distraction?
David Sidebotham

Panel Discussion 30 minutes

Session 4:

Fine Tuning the Metabolism of the Cardiac Surgical Patient (3)

What’s the correct glucose target in diabetics
Rinaldo Bellomo

Glucose management workshop: patient directed therapy, what you are doing?

Panel Discussion 30 minutes

Session 5:

Public Reporting

“All for one and one for all: the public release of the outcomes of cardiac surgery.”
Alan Merry

1400 – 1700
Session 6:

Team Activity
Delegates will be assigned into multidisciplinary teams prior to departure to an off-site outdoor Central Otago location. The teams will split to alternate two separate 45 minute sessions undertaking a range of (supervised) challenges requiring communication, solution finding, delegation and interpersonal management skills to achieve optimal outcomes. Aggregate team points awarded by task supervisors will determine the teamwork team winner.

1730 – 1830
To follow off site
Session 7: Prof Merry Lecture
The Uneasiness of Change

Rob Baker 

Casual Dinner

Saturday 20th August 2016
Session 8:

Little Hearts – Big Challenges

The Odyssey by Homer Horton (30 min)
Steve Horton

“Challenges and controversies in Paediatric Cardiac Surgery”
Tim Jones

Panel Discussion 30 minutes

Session 9:

Driving Change

Continuous measurement of urinary oxygen tension: a biomarker of risk of acute kidney injury.
Andrew Cochrane

“I cannot tell a lie! The statistician did it!”
Alan Merry

Making data drive change

Panel Discussion 30 minutes

1330-1500 Session 10:

Confounders and Collaborators

Disruptions and Distractions in the CVOR
Joyce Wahr

UK Perfusion Good Practice Guide: to a systems-based approach to delivering a perfusion service
Tim Jones

Panel Discussion 30 minutes

Session 11:

Managing the Unexpected: Error and a lot more

Reporting Mishaps
Tim Willcox

Learning from Defects
Joyce Wahr

Closing Remarks

Farewell Dinner


Call for Abstracts – Perfusion Downunder Winter Meeting 2016

Call for Abstracts

You are invited to contribute a paper in any one of the themes outlined below. Abstracts must be submitted no later than the 1st June 2016.

Abstracts will be reviewed by the Abstract Grading Committee and may be accepted to any part of the meeting. The Scientific Program Committee reserves the right to assign accepted papers to any of the presentation formats. All presentation formats will form integral elements of the Scientific Program. An author may submit more than one abstract.

Follow the guidelines exactly as abstracts will not be retyped. Abstracts not complying with the guidelines may be withdrawn by the Scientific Program Committee.

Abstracts are invited on all aspects of Perfusion and related topics, research and clinical papers are welcome.

Papers will be presented as either free short (10 min) or long papers (15 min), or included as a focus point in a workshop.

In addition topics for inclusion in symposium and workshops are sought from participants at all times.


Abstract format instructions:

  • See the example below and follow the format exactly. Title, authors and institutions must be included in the document you submit.
  • Select arial font type size 10.
  • Abstract word limit is 250. The word limit relates only to the text of the abstract and does not include title, authors and institutions.
  • The complete abstract must be no more than 15cm wide and 12cm in length.
  • Use single line spacing.
  • TITLE should be in UPPER CASE, bold and at the top of the abstract.
  • The name of the presenting author to be indicated by an underlining (Michael McDonald CCP (Aust), Robert A Baker CCP (Aust), Timothy Willcox CCP (Aust)). The authors’ names (Christian Middle initial Surname, highest degree) should be followed by the institution, city, country (Sentence case).
  • Abbreviations may be used but must be spelt out in full at the first mention followed by the abbreviation in parentheses.
  • Please proof read your abstract carefully.




Jee-Yoong Leong MB BS, Vijit Cherian MCh, Robert A Baker PhD, John L Knight FRACS Cardiac and Thoracic Surgical Unit, Flinders Medical Centre, Bedford Park, South Australia, AUSTRALIABackground. Aspirin is the main antiplatelet medication used in patients with coronary artery disease, however there is growing evidence that the use of the more potent clopidogrel, on its own or in combination with aspirin, has superior outcomes. Clopidogrel has also been shown to increase the risk of bleeding after coronary artery bypass graft surgery, which is a significant cause of morbidity and mortality. We review the effect of the use of preoperative clopidogrel on bleeding-related complications after coronary artery bypass graft surgery in our institution. 

Methods. A retrospective analysis of all patients undergoing isolated coronary artery bypass graft surgery at the Flinders Medical Centre between July 2000 and June 2003. A comparison was made between patients who received preoperative clopidogrel with those who did not receive it. Also, a comparison was made between patients who were on clopidogrel only, aspirin only and neither medication.

Results. A total of 919 patients were identified, of which 88 (9.6%) were on preoperative clopidogrel. Clopidogrel recipients had a higher volume of drain loss, were transfused more units of blood, and had longer intensive care unit and postoperative hospital stays than patients not exposed to clopidogrel.

Conclusions. In the three year period studied, the data from our institution showed an increased risk of bleeding, blood transfusion and resource utilization in patients who were on clopidogrel before coronary artery bypass graft surgery.



Abstract Submissions

Electronic abstracts submission is preferred.
Email completed abstract (word document)
Include in your email the presenter’s name, address, and telephone number.

Email Submission to

Speaker Timeline
Deadline for receipt of abstracts
June 1, 2016
Notification of acceptance
June 8, 2016

Speaker Expenses
All presenters are required to pay their own registration, accommodation and travel expenses.